02 May 2003
Poly(ADP-ribose) polymerase (PARP) in the pathogenesis of diabetic complications
C. SzaboMed Sci Monit 2003; 9(1): 67-0 :: ID: 15206
Abstract
Poly(ADP ribose) polymerase (PARP) is an abundant nuclear enzyme of eukaryotic cells, which has been implicated in response to DNA injury. Free radical and oxidant induced cell injury can involve the activation of PARP. PARP, when activated by DNA single-strand breaks, initiates an energy consuming cycle by transferring ADP ribose units from NAD to nuclear proteins. The results of this process is a rapid depletion of the intracellular NAD and ATP pools which slows the rate of glycolysis and mitochondrial respiration leading to cellular dysfunction. Recent studies from our group demonstrated the importance of PARP pathway for the pathogenesis of diabetic macrovascular dysfunction, retinopathy and cardiomyopathy. Here we overview our recent progress in the field, which includes (1) delineation of novel molecular mechanisms of the PARP-mediated cellular dysfunction in diabetes, including the link between PARP and pro-inflammatory mediator expression and a link between PARP activation and GAPDH activity suppression; (2) regulation of inflammatory mediator expression by PARP in response to oscillating glucose conditions; (3) recent evidence for PARP activation in tissue specimens of human diabetic patients and (4) recent evidence showing PARP activation in various rodent models of neuropathy, as well as demonstration of the prevention or restoration of the suppression of nerve blood flow and conduction deficit by pharmacological PARP inhibition as well as by genetic PARP deficiency. Overall, PARP emerges as an important novel potential drug target for the correction of various forms of diabetic complications. References: 1.Virág L, Szabó C: The therapeutic potential of PARP inhibition. Pharmacological Reviews, 2002; 54: 375-429 2.Soriano FG, Virág L, Jagtap P et al: Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nature Medicine, 2001; 7: 108-113 3.Pacher P, Liaudet L, Soriano FG et al: The role of poly(ADP-ribose) polymerase in the development of myocardial and endothelial dysfunction in diabetes mellitus. Diabetes, 2002; 51: 514-521
Keywords: vascular dysfunction, endothelium-dependent relaxation, Hyperglycemia, peroxynitrite
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952